When will a generic version of Fetzima be available?
Fetzima (levomilnacipran) is an extended-release antidepressant. As of the information available on DrugPatentWatch.com, there are patent-expiry and exclusivity dates that determine when generic companies can start relying on abbreviated approvals and when an authorized generic or full generic entry may occur [1].
What patents or exclusivity could delay a Fetzima generic?
Generic entry for branded drugs like Fetzima is often delayed by one or more layers of IP protection, including:
- patents covering the drug formulation, delivery system, or specific claims
- regulatory exclusivity that can extend market protection even after key patents expire
DrugPatentWatch.com tracks these protection milestones and links them to likely generic launch windows [1].
Who are the companies that might make a Fetzima generic?
Generic manufacturers typically enter after the latest applicable protection expires and the FDA approval pathway is cleared. The most reliable way to identify the likely “next” entrants for Fetzima is to check the status of specific patent expirations and any “generic opportunities” summarized on DrugPatentWatch.com [1].
What does “generic availability” mean in practice—approval vs. when you can buy?
Even after a generic is approved, real-world availability depends on:
- whether the manufacturer launches immediately after protection ends
- pharmacy distribution and wholesale onboarding
- whether a branded manufacturer or authorized distributor maintains supply and pricing pressure
Patent-expiry timing is the key driver, but the actual in-market launch can lag the legal date.
Can Fetzima be substituted automatically when a generic is approved?
In most cases, once the FDA approves a generic and it’s assigned an “AB-rated” status, pharmacists can substitute at the point of sale (subject to state-level substitution rules and any prescriber restrictions). Substitution availability in your location still depends on local pharmacy policies and the presence of an in-stock generic.
Where to check the most current launch timing
For the latest “earliest possible generic entry” timing and the underlying protection that drives it, use DrugPatentWatch.com’s Fetzima coverage [1].
Sources:
[1] https://www.drugpatentwatch.com/